Innovating medicines
for breast cancer and beyond.
Innovating medicines
for breast cancer and beyond.
Innovating medicines
for breast cancer and beyond.
Pursuing better treatments to help patients feel better, longer.
Bring your passion, join our team and make your mark.
Olema's latest news and recent events.
-
March 4th, 2025 Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
February 19th, 2025 Olema Oncology to Present at the TD Cowen 45th Annual Health Care Conference
-
February 18th, 2025 Olema Oncology Appoints Shawnte M. Mitchell, J.D. as Chief Legal Officer and Corporate Secretary
-
February 4th, 2025 Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
February 3rd, 2025 Olema Oncology to Participate in Upcoming Investor Conferences
-
January 3rd, 2025 Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
March 4th, 2025 Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
February 19th, 2025 Olema Oncology to Present at the TD Cowen 45th Annual Health Care Conference
-
February 18th, 2025 Olema Oncology Appoints Shawnte M. Mitchell, J.D. as Chief Legal Officer and Corporate Secretary
-
February 4th, 2025 Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
February 3rd, 2025 Olema Oncology to Participate in Upcoming Investor Conferences
-
January 3rd, 2025 Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Item 1 of 6